Dare Bioscience, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
DARE chart
What traders are saying about $DARE
Latest postsDare Bioscience, Inc. news
- DARE: Stockholders approved the warrant-share issuance proposal and conditional adjournment
TradingView ·
- Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026
Yahoo Finance ·
- A results webcast will be available for 90 days after Daré Bioscience's Nov. 16 call.
Stock Titan ·
- Daré Bioscience, Inc. (DARE) stock price, news, quote and history
Yahoo Finance UK ·
- Daré Bioscience Releases Next Episode in “CEO Corner” Video Series
Yahoo Finance ·
- Dare Bioscience Inc expected to post a loss of 26 cents a share - Earnings Preview
TradingView ·
- Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
Yahoo Finance ·
- The public can watch Daré Bioscience's CEO discuss women's health online Nov. 11.
Stock Titan ·
- DARE Q3'26 Earnings: EPS estimate is (0.13) USD
TradingView ·
- Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
Yahoo Finance ·
- Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion
Yahoo Finance ·
- Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
Yahoo Finance ·
Dare Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.0M | $9,784 | $2.8M | $10.0M |
| Net income | -$13.4M | -$4.0M | -$30.2M | -$30.9M |
| Diluted EPS | $-1.20 | $-0.48 | $-4.15 | $-0.37 |
| Total assets (year end) | $32.5M | $22.1M | $21.3M | $43.8M |
| Cash and equivalents (year end) | $24.7M | $15.7M | $10.5M | $34.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Dare Bioscience, Inc.
- Ticker
- DARE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1401914
- Former names
- Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
Frequently asked questions
What exchange is Dare Bioscience, Inc. listed on?
Dare Bioscience, Inc. trades on the Nasdaq under the ticker symbol DARE.
What industry is Dare Bioscience, Inc. in?
Dare Bioscience, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Dare Bioscience, Inc. headquartered?
Dare Bioscience, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Dare Bioscience, Inc.'s fiscal year end?
Dare Bioscience, Inc.'s fiscal year ends on December 31.
How much revenue did Dare Bioscience, Inc. report?
Dare Bioscience, Inc. reported $1.0M in revenue for calendar year 2025, according to its SEC filings.